login
  Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

ViewFlex Xtra Intracardiac Echocardiography catheter gets FDA clearance


Tuesday, 10 Jul 2012 15:08
ViewFlex Xtra ICE catheter
ViewFlex Xtra ICE catheter

The US Food and Drug Administration (FDA) has given 510(k) clearance to St Jude Medical to market its ViewFlex Xtra Intracardiac Echocardiography (ICE) catheter. This new technology is designed to be used with the ViewMate Z Ultrasound console, a system that provides fast, clear images to help visualise cardiac structures and blood flow within the heart during complex electrophysiology or interventional procedures.


The images produced by the ViewFlex Xtra ICE catheter and the ViewMate Z Ultrasound console help physicians confirm the location of cardiac structures and blood flow during procedures such as radiofrequency ablation to treat arrhythmias and structural heart procedures to close atrial septal defects.

The ViewFlex ICE catheter has an ergonomic handle allowing for single handed, four-way tip deflection and self-locking steering. The new handle helps streamline procedures by providing increased maneuverability with the potential to minimise catheter repositioning.


“The ViewFlex Xtra catheter offers an advancement to the ViewMate Z Ultrasound console through its four-way tip deflection, a feature that allows physicians to more easily obtain desired viewing angles of the cardiac anatomy,” said Dhanunjay Lakkireddy, professor of Medicine and director of the Center for Excellence in Atrial Fibrillation and EP Research from the University of Kansas Medical Center in Kansas City, USA, who first used the new ViewFlex Xtra ICE Catheter. “The wide range of viewing options and high-quality images allow me to focus more on the patient and less on the catheter.”




Add New Comment

Most popular


Friday, 22 Aug 2014
Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration to market its precision planning application for transcatheter aortic-valve implantation (TAV... FDA 510(k) clearance for TAVI precision treatment planning application

Joint consensus on antithrombotic use in AF patients with acute coronary syndrome published
Wednesday, 27 Aug 2014
A new European joint consensus document on the use of antithrombotic drugs in patients with atrial fibrillation presenting with an acute coronary syndrome and undergoing percutaneous coronary ... Joint consensus on antithrombotic use in AF patients with acute coronary syndrome published

No severe paravalvular leak with Acurate Neo TF
Monday, 29 Sep 2014
Data presented at PCR London Valves (28–30 September, London, UK) indicate that the Acurate Neo transfemoral TAVI system, which recently received the CE mark, is not associated with any incidences of ... No severe paravalvular leak with Acurate Neo TF

Features


The promise of chemical renal denervation
Friday, 05 Sep 2014
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based “burning” technologies. The promise of chemical renal denervation

Drug-coated balloons for the management of coronary artery disease
Thursday, 04 Sep 2014
Robert Byrne writes that although drug-coated balloon therapy has been a significant innovation with relevance for everyday practice, convincing data in the coronary arena exists thus far only for ... Drug-coated balloons for the management of coronary artery disease

Profiles


Azeem Latib
Wednesday, 24 Sep 2014
Azeem Latib (senior interventional cardiologist, San Raffaele Hospital and EMO-GVM Centro Cuore C... Azeem Latib

David J Cohen
Wednesday, 04 Jun 2014
David J Cohen, director, Cardiovascular Research, Saint Luke’s Mid America Heart Institute, Kansas C... David J Cohen

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions